Cargando…
The clinical landscape for SMA in a new therapeutic era
Despite significant advances in basic research, the treatment of degenerative diseases of the nervous system remains one of the greatest challenges for translational medicine. The childhood onset motor neuron disorder spinal muscular atrophy (SMA) has been viewed as one of the more tractable targets...
Autores principales: | Talbot, K, Tizzano, E F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628264/ https://www.ncbi.nlm.nih.gov/pubmed/28644430 http://dx.doi.org/10.1038/gt.2017.52 |
Ejemplares similares
-
Perspectives in genetic counseling for spinal muscular atrophy in the new therapeutic era: early pre-symptomatic intervention and test in minors
por: Serra-Juhe, Clara, et al.
Publicado: (2019) -
Recommendations for Interpreting and Reporting Silent Carrier and Disease-Modifying Variants in SMA Testing Workflows
por: Milligan, John N., et al.
Publicado: (2022) -
New Directions for SMA Therapy
por: Messina, Sonia
Publicado: (2018) -
Phosphatase and tensin homologue: a therapeutic target for SMA
por: Godena, Vinay K, et al.
Publicado: (2017) -
Beyond copy number: A new, rapid, and versatile method for sequencing the entire SMN2 gene in SMA patients
por: Blasco‐Pérez, Laura, et al.
Publicado: (2021)